Skip to content
About
Clinical Trials
Resources
Contact
Menu
About
Clinical Trials
Resources
Contact
HEAT Trial
Bifunctional antibody against EGFR and TGF Beta, alone and in combination with pembrolizumab for Head and neck cancer, NSCLC and anal cancer and cutaneous squamous cell cancer
Status:
Open
Trial Type:
Early Phase Trials for Multiple Cancer Types
,
Head and Neck Cancer
,
Lung Cancer
,
Melanoma and Skin Cancers
Contact:
Dr. Ari Birnbaum
abirnbaum@lifespan.org